However, the number of participants in the STHLM3-MRI experimental group with clinically significant cancer detected after PSA testing and MRI was substantially higher in the first screening round (192 of 7609 [2.5%])3 than in the second (48 of 7609 [0.6%]). This evidence concerns the gene KLK3 and cancer.